78110-38-0 | Aztreonam

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	in stock	$8.00	$5.00
250mg	95%	in stock	$26.00	$18.00
1g	95%	in stock	$41.00	$29.00
5g	95%	in stock	$81.00	$57.00
10g	95%	in stock	$137.00	$96.00
25g	95%	in stock	$249.00	$175.00
100g	95%	in stock	$758.00	$531.00

Description

• Catalog Number: AI66142
• Chemical Name: Aztreonam
• CAS Number: 78110-38-0
• Molecular Formula: C13H17N5O8S2
• Molecular Weight: 435.4328
• MDL Number: MFCD00072145
• SMILES: C[C@H]1[C@H](NC(=O)C(=NOC(C(=O)O)(C)C)c2csc(n2)N)C(=O)N1S(=O)(=O)O
• NSC Number: 646279

Computed Properties

• Complexity: 808
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 2
• Defined Bond Stereocenter Count: 1
• Heavy Atom Count: 28
• Hydrogen Bond Acceptor Count: 12
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 7
• XLogP3: 0.3

Literature

• β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.

  Chemical research in toxicology 20130617

• In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.

  The Journal of antimicrobial chemotherapy 20121101

• Desensitization to inhaled aztreonam lysine in an allergic patient with cystic fibrosis using a novel approach.

  The Annals of pharmacotherapy 20121001

• [Revival of selected well-tried antibiotics. Special features of the antiinfective agents penicillin G, fosfomycin, aztreonam and colistin].

  Medizinische Monatsschrift fur Pharmazeuten 20121001

• A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.

  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20120901

• Early response of ceftaroline fosamic in the treatment of soft-tissue infections.

  Expert review of clinical pharmacology 20120901

• The use of nebulised aztreonam lysine (AZLI) in aztreonam hypersensitive patients.

  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20120701

• Analysis of aztreonam-inducing proteome changes in nondividing filamentous Helicobacter pylori.

  Current microbiology 20120701

• Inhaled antibiotics in cystic fibrosis: what's new?

  Journal of the Royal Society of Medicine 20120601

• Necrotizing pneumonia caused by group C streptococci in a young adult.

  Respiratory care 20120301

• Potent inhibitors of LpxC for the treatment of Gram-negative infections.

  Journal of medicinal chemistry 20120126

• Aztreonam lysine for inhalation: new formulation of an old antibiotic.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120115

• In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan.

  Japanese journal of infectious diseases 20120101

• Decreased aztreonam susceptibility among Pseudomonas aeruginosa isolates from hospital effluent treatment system and clinical samples.

  International journal of environmental health research 20120101

• Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.

  PloS one 20120101

• Inhaled aztreonam lysine for cystic fibrosis pulmonary disease-related outcomes.

  The Annals of pharmacotherapy 20120101

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics.

  Respiratory medicine 20111201

• Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

  Expert review of anti-infective therapy 20111101

• Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).

  The Journal of antimicrobial chemotherapy 20111001

• New Delhi metallo-β-lactamase (NDM-1): an update.

  Journal of chemotherapy (Florence, Italy) 20111001

• Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa.

  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20110701

• Aztreonam for inhalation (Cayston) for cystic fibrosis.

  The Nurse practitioner 20110601

• Synthetic inter-species cooperation of host and virus for targeted genetic evolution.

  Journal of biotechnology 20110420

• Aztreonam lysine for inhalation solution in cystic fibrosis: profile report.

  Paediatric drugs 20110401

• Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20110401

• An unexpected similarity between antibiotic-resistant NDM-1 and beta-lactamase II from Erythrobacter litoralis.

  Protein & cell 20110301

• Pharmacokinetics of aztreonam after intravenous administration in foals.

  Journal of veterinary pharmacology and therapeutics 20110201

• Tolerability of aztreonam in patients with cell-mediated allergy to β-lactams.

  International archives of allergy and immunology 20110101

• A predictive ligand-based Bayesian model for human drug-induced liver injury.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• Synthesis and antimicrobial evaluation of some fused heterocyclic [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.

  European journal of medicinal chemistry 20101201

• An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.

  Pediatric pulmonology 20101101

• Transcriptomic and phenotypic characterization of a Bacillus subtilis strain without extracytoplasmic function σ factors.

  Journal of bacteriology 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

  The Journal of antimicrobial chemotherapy 20101101

• CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

  The Journal of antimicrobial chemotherapy 20101101

• Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

  The Journal of antimicrobial chemotherapy 20101101

• Aztreonam lysine for inhalation solution: in cystic fibrosis.

  Drugs 20101001

• Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20101001

• Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100915

• Aztreonam for inhalation solution (Cayston) for cystic fibrosis.

  The Medical letter on drugs and therapeutics 20100809

• Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis.

  Expert review of respiratory medicine 20100801

• Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine.

  Expert opinion on pharmacotherapy 20100601

• Inhaled aztreonam.

  Nature reviews. Drug discovery 20100501

• [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].

  Revue des maladies respiratoires 20100501

• The catalytic efficiency (kcat/Km) of the class A beta-lactamase Toho-1 correlates with the thermal stability of its catalytic intermediate analog.

  Biochimica et biophysica acta 20100401

• Update in cystic fibrosis 2009.

  American journal of respiratory and critical care medicine 20100315

• Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.

  Journal of medicinal chemistry 20100114

• [Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland].

  Medycyna doswiadczalna i mikrobiologia 20100101

• Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers.

  Diagnostic microbiology and infectious disease 20091001

• Lack of pharmacokinetic drug interactions following concomitant administration of telavancin with aztreonam or piperacillin/tazobactam in healthy participants.

  Journal of clinical pharmacology 20090701

• Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa.

  Journal of medical microbiology 20090501

• Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.

  Chest 20090501

• Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.

  Journal of pediatric hematology/oncology 20090401

• [Checkerboard-plate screening synergistic aztreonam and aminoglicoside combination effects against multidrug-resistant Pseudomonas aeruginosa].

  Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20090301

• A case of multidrug-resistant Salmonella enterica serovar Typhi treated with a bench to bedside approach.

  Yonsei medical journal 20090227

• In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.

  BMC infectious diseases 20090101

• Contribution towards developing a new semi-selective medium for Streptococcus anginosus group.

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20090101

• Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.

  American journal of respiratory and critical care medicine 20081101

• First characterization and emergence of SHV-60 in raw milk of a healthy cow in Japan.

  The Journal of veterinary medical science 20081101

• Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.

  Journal of chemotherapy (Florence, Italy) 20081001

• [Case of sepsis caused by multidrug-resistant neutropenic-phase Pseudomonas aeruginosa treated successfully with antibiotic combination therapy].

  Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20080901

• What did we learn from the North American Cystic Fibrosis Conference?

  Journal of the Royal Society of Medicine 20080701

• Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China.

  Japanese journal of infectious diseases 20080701

• First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.

  Journal of infection in developing countries 20080601

• [Infection treatment caused by multiple-drug-resistant Pseudomonas aeruginosa in a patient undergoing allogeneic hematopoietic stem cell transplantation].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080401

• Ciprofloxacin-induced Q-T interval prolongation.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080315

• A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.

  Pediatric pulmonology 20080101

• Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.

  The Indian journal of medical research 20080101

• Tolerability of aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams.

  International journal of immunopathology and pharmacology 20080101

• [Is aztreonam could become 'a challenger' for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].

  Pathologie-biologie 20071201

• MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate.

  Bioorganic & medicinal chemistry 20071115

• Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa.

  Infection control and hospital epidemiology 20071001

• Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis.

  Journal of medical microbiology 20071001

• Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis.

  Journal of applied microbiology 20071001

• Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.

  Antimicrobial agents and chemotherapy 20070701

• [Cefepime and aztreonam shortages: we've run out of ammo].

  Enfermedades infecciosas y microbiologia clinica 20070501

• Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

  International journal of antimicrobial agents 20070301

• Treatment of infections caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20070201

• Successful treatment of Pasteurella multocida meningitis with aztreonam.

  Scandinavian journal of infectious diseases 20070101

• Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.

  Microbial drug resistance (Larchmont, N.Y.) 20070101

• [Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].

  Medycyna doswiadczalna i mikrobiologia 20070101

• MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituents.

  Bioorganic & medicinal chemistry 20061215

• Transient neutrophilic thrombophagocytosis associated with Citrobacter freundii septicemia.

  Archives of pathology & laboratory medicine 20061201

• Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20061201

• Effects of beta-lactam antibiotics and L-arginine in the treatment of experimental sepsis in rats.

  International journal of antimicrobial agents 20061101

• Nosocomial infection with cephalosporin-resistant Klebsiella pneumoniae is not associated with increased mortality.

  Infection control and hospital epidemiology 20060901

• High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20060801

• Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.

  Pediatric pulmonology 20060701

• Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.

  Journal of microbiological methods 20060601

• Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.

  The Annals of pharmacotherapy 20060601

• Assessing the protonation state of drug molecules: the case of aztreonam.

  Journal of medicinal chemistry 20060601

• Cefepime vs. Ampicillin/Sulbactam and Aztreonam as antibiotic prophylaxis in neurosurgical patients with external ventricular drain: result of a prospective randomized controlled clinical trial.

  Journal of clinical pharmacy and therapeutics 20060601

• [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].

  The Japanese journal of antibiotics 20060601

• Treatment of culture-negative skull base osteomyelitis.

  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20060201

• [The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].

  The Japanese journal of antibiotics 20060201

• Molecular dynamics simulations of class C beta-lactamase from Citrobacter freundii: insights into the base catalyst for acylation.

  Biochemistry 20060117

• Erythroderma due to aztreonam and clindamycin.

  Journal of investigational allergology & clinical immunology 20060101

• A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli.

  Enfermedades infecciosas y microbiologia clinica 20060101

• Successful treatment of Pasteurella multocida meningitis with aztreonam.

  Scandinavian journal of infectious diseases 20060101

• In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii.

  Journal of chemotherapy (Florence, Italy) 20051201

• A deficiency in S-adenosylmethionine synthetase interrupts assembly of the septal ring in Escherichia coli K-12.

  Molecular microbiology 20051101

• The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050901

• Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia.

  The Journal of antimicrobial chemotherapy 20050901

• Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20050901

• Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.

  Journal of pharmaceutical sciences 20050701

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Continuous infusion beta-lactams for intensive care unit pulmonary infections.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050501

• Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.

  International journal of antimicrobial agents 20050501

• Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.

  Bioorganic & medicinal chemistry letters 20050415

• Pilot study for the development of a new campylobacter selective medium at 37 degrees C using aztreonam.

  Journal of clinical pathology 20050401

• Stability of aztreonam in AZACTAM.

  Farmaco (Societa chimica italiana : 1989) 20050101

• [The occurrence and characterisation of oxy-imino-beta-lactams resistant strains among Salmonella enterica subsp. enterica isolated in Poland].

  Medycyna doswiadczalna i mikrobiologia 20050101

• Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.

  International journal of antimicrobial agents 20041201

• In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.

  International journal of antimicrobial agents 20040601

• In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.

  The Kaohsiung journal of medical sciences 20040601

• Aztreonam.

  Indian pediatrics 20040401

• The combination of aztreonam and cefozopran against Stenotrophomonas maltophilia.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20040201

• Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers.

  International journal of antimicrobial agents 20040201

• Using nanoparticle optics assay for direct observation of the function of antimicrobial agents in single live bacterial cells.

  Biochemistry 20040113

• Inhaled antibiotics.

  Pediatric pulmonology. Supplement 20040101

• Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli.

  Diagnostic microbiology and infectious disease 20031101

• Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.

  Diagnostic microbiology and infectious disease 20030901

• Sepsis in a renal transplant recipient due to Citrobacter braakii.

  Southern medical journal 20030801

• Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.

  American journal of clinical oncology 20030601

• Piperacillin plus aztreonam for treatment of neutropenic fever.

  Pediatrics international : official journal of the Japan Pediatric Society 20030601

• Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates.

  International journal of medical microbiology : IJMM 20030601

• In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.

  Chemotherapy 20030501

• Spectrophotometric and fluorimetric determination of aztreonam in bulk and dosage forms.

  Journal of pharmaceutical and biomedical analysis 20030326

• An approach for the evaluation of synergy between antimicrobials.

  International journal of antimicrobial agents 20030301

• Aztreonam treatment of Pasteurella multocida cellulitis and bacteremia.

  The Annals of pharmacotherapy 20030301

• Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from 1998-2002.

  Connecticut medicine 20030301

• Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.

  Clinical therapeutics 20030301

• A dynamic structure for the acyl-enzyme species of the antibiotic aztreonam with the Citrobacter freundii beta-lactamase revealed by infrared spectroscopy and molecular dynamics simulations.

  Biochemistry 20030225

• Differential modulation of the induction of inflammatory mediators by antibiotics in mouse macrophages in response to viable Gram-positive and Gram-negative bacteria.

  Journal of endotoxin research 20030101

• [Characteristics and clinical value of extended-spectrum beta-lactamases].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20030101

• [In vitro antibacterial activity and beta-lactamase stability of meropenem].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20030101

• Simple intravenous antimicrobial desensitization method for pediatric patients.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020815

• Detection of extended spectrum beta-lactamases in the routine clinical microbiology laboratory.

  Pathology 20020801

• Secondary-site mutation restores the transport defect caused by the transmembrane domain mutation of the xenobiotic transporter MexB in Pseudomonas aeruginosa.

  Biochemical and biophysical research communications 20020329

• Severe cellulitis/myositis caused by Stenotrophomonas maltophilia.

  The Annals of pharmacotherapy 20020101

• In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.

  Diagnostic microbiology and infectious disease 20020101

• Susceptibility of Streptococcus mutans and Streptococcus sobrinus to cell wall inhibitors and development of a novel selective medium for S. sobrinus.

  Caries research 20020101

• Mycotic aneurysm of the descending thoracic aorta caused by Pseudomonas aeruginosa in a solid organ transplant recipient: case report and review.

  Surgical infections 20020101

• Distribution of the Escherichia coli structural maintenance of chromosomes (SMC)-like protein MukB in the cell.

  Molecular microbiology 20011201

• Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model.

  Alimentary pharmacology & therapeutics 20011101

• Traveler's diarrhea.

  Gastroenterology clinics of North America 20010901

• Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase.

  The Journal of hospital infection 20010801

• Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients.

  Clinical therapeutics 20010801

• Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010515

• Beta-lactam antibiotic-mediated changes in platelet reactivity and vascular endothelial functions.

  Pharmacology & toxicology 20010501

• SHV-27, a novel cefotaxime-hydrolysing beta-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital.

  The Journal of antimicrobial chemotherapy 20010401

• Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.

  Annals of surgical oncology 20010301

• In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.

  International journal of antimicrobial agents 20010301

• Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20010301

• Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010201

• The effect of acetazolamide on the kinetics of four newer beta-lactams in the aqueous humor.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010201

• Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals.

  Diagnostic microbiology and infectious disease 20010101

• beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium.

  Scandinavian journal of infectious diseases 20010101

• In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.

  Diagnostic microbiology and infectious disease 20010101

• Comparison of aztreonam against other antibiotics used in urinary tract infections.

  Journal of Ayub Medical College, Abbottabad : JAMC 20010101

• Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates.

  Antimicrobial agents and chemotherapy 19980601

• Comparative epileptogenic properties of two monobactam derivatives in C57, Swiss and DBA/2 mice.

  The Journal of antimicrobial chemotherapy 19960901

• Cefotetan disodium-induced hemolytic anemia.

  The Annals of pharmacotherapy 19920201

• Epitope analysis of aztreonam by antiaztreonam monoclonal antibodies and possible consequences in beta-lactams hypersensitivity.

  International archives of allergy and immunology 19920101

• Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis.

  The Journal of allergy and clinical immunology 19910101

• Aztreonam in the treatment of gram-negative bacterial meningitis.

  Reviews of infectious diseases 19910101

• Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and/or cephalosporin antibiotics.

  Reviews of infectious diseases 19910101

• In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteria.

  The Journal of antimicrobial chemotherapy 19881201

• Acute renal failure, skin rash, and eosinophilia associated with aztreonam.

  American journal of nephrology 19880101

• Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.

  Antimicrobial agents and chemotherapy 19871001

• Azthreonam in the treatment of urinary tract infection: evaluation of efficacy, renal effects and nephrotoxicity.

  Drugs under experimental and clinical research 19870101

• Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis.

  Reviews of infectious diseases 19850101

• Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria.

  Reviews of infectious diseases 19850101